With healthier finances, Clover Bio shifts to flu and RSV vaccines
The Chinese vaccine developer rebounded from a deep loss into profit in the first half of the year, boosted by a one-off gain from a Covid research grant Key Takeaways:…
FAST NEWS: Clover Bio Gets Exclusive Rights for Imported Flu Vaccine
The latest: Clover Biopharmaceuticals Ltd. (2197.HK) said on Monday it has reached an exclusive agreement to import Adimmune Corp.’s quadrivalent seasonal influenza vaccine AdimFlu-S (QIS) to China. It added it will…
